フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
AstraZeneca PLC on Monday said Datroway has been approved in the US for patients with a type of breast cancer. The C ...
AstraZeneca PLC 20 January 2025 20 January 2025 Datroway (datopotamab deruxtecan) approved in the US for patients with previously...
AstraZeneca PLC on Friday said its drug Calquence, in combination with chemoimmunotherapy, has received approval from ...
AstraZeneca PLC 17 January 2025 17 January 2025 Calquence plus chemoimmunotherapy approved in the US for patients with previously untreated...
AstraZeneca PLC on Monday said its lung cancer treatment, co-developed with Daiichi Sankyo Co Ltd, is under priority ...
Patients in England with a form of breast cancer will be offered a new treatment after it was given the green light f ...
AstraZeneca PLC 02 January 2025 2 January 2025 Transparency Directive Voting rights and capital The following notification is made in...
AstraZeneca PLC and its Japanese partner Daiichi-Sankyo Co Ltd have withdrawn an application in the European Union fo ...
AstraZeneca PLC 24 December 2024 24 December 2024 Datopotamab deruxtecan application in the EU for patients with advanced nonsquamous...
AstraZeneca PLC on Monday said it has received approval in the European Union for Tagrisso, its non-small cell lung c ...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約